Close Menu

This story has been updated to include comments from Roche Diagnostics.

NEW YORK – A new study in the Journal of Molecular Diagnostics has demonstrated an HPV assay from startup Atila Biosystems performs comparably to standard-of-care testing from Roche Diagnostics. The low-cost, high-throughput, multiplex isothermal system was also shown to perform well using formalin-fixed, paraffin-embedded cervical and orophyrengeal samples without any nucleic acid extraction.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.